To assess the effects of preadmission functional impairment on Medicare costs of postacute care up to 365 days after hospital discharge. DESIGN: Longitudinal cohort study. SETTING: Health and Retirement Study (HRS). PARTICIPANTS: Nationally representative sample of 16,673 Medicare hospitalizations of 8,559 communitydwelling older adults from 2000 to 2012. MEASUREMENTS: The main outcome was total Medicare costs in the year after hospital discharge, assessed according to Medicare claims data. The main predictor was functional impairment (level of difficulty or dependence in activities of daily living (ADLs)), determined from HRS interview preceding hospitalization. Multivariable linear regression was performed, adjusted for age, race, sex, income, net worth, and comorbidities, with clustering at the individual level to characterize the association between functional impairment and costs of postacute care. RESULTS: Unadjusted mean Medicare costs for 1 year after discharge increased with severity of impairment in a dose-response fashion (P < .001 for trend); 68% had no functional impairment ($25,931), 17% had difficulty with one ADL ($32,501), 7% had dependency in one ADL ($39,928), and 8% had dependency in two or more ADLs ($45,895). The most severely impaired participants cost 77% more than those with no impairment; adjusted analyses showed attenuated effect size (33% more) but no change in trend. Considering costs attributable to comorbidities, only three conditions were more expensive than severe functional impairment (lymphoma, metastatic cancer, paralysis).
C osts of care for Medicare beneficiaries are a top priority for healthcare reform and an topic of increasing concern in broader public policy debates on overall government spending in the United States. 1 Recent studies have attributed rising per-beneficiary Medicare costs to increasing prevalence of chronic conditions, [2] [3] [4] with beneficiaries with multimorbidity representing a disproportionate share. 5 Accordingly, current Medicare policies for cost containment prioritize specific conditions such as heart failure. Identifying individual-level factors that drive use and costs for multiple conditions and care settings has proven elusive.
Functional status is an excellent indicator of overall disease burden, 6 and a robust literature suggests it may indicate more about overall health status than conditionspecific markers because it is a direct measure of the end effect of all the person's illnesses. [7] [8] [9] [10] Recent research has suggested that functional impairment outperforms comorbidity in predicting outcomes of acute care such as readmission, [12] [13] [14] [15] [16] but very few studies have examined postacute costs associated with functional impairment. These studies have shown greater costs with higher levels of functional impairment, but they have been limited to individuals admitted for acute stroke. 17, 18 Although functional assessment is often part of routine care for these individuals, functional status is not routinely assessed in acute care hospitals and is not reported to Medicare in hospital claims data. Given the strong associations between functional status and other outcomes of hospitalization for many conditions, it may be that functional status is an "unmeasured" individual-level marker of postacute care use and costs in the general population of hospitalized Medicare beneficiaries.
Acute care transitions are a major focus of costreduction reforms in the Affordable Care Act because hospital admissions are high-cost episodes of care. 19 These programs, such as readmission penalties and bundled payments, focus on the hospital stay and a transition period up to 30 days after discharge, 20 but it is likely that this focus captures only a portion of postacute costs, which are now the fastest-growing and most geographically variable component of Medicare spending. [21] [22] [23] Moreover, incident hospitalization identifies a subset of high-cost Medicare beneficiaries who are likely to require repeated episodes of acute and postacute care, yet data about what drives costs in these individuals over time are limited. Only a few studies have directly examined the relationship between functional impairment and costs in community (nonhospital) settings, 24, 25 and none have explored functional impairment as a marker of Medicare costs for hospitalized older adults during the postacute phase of care.
To address these gaps, longitudinal, nationally representative survey data from the Health and Retirement Study (HRS), which includes uniform functional assessments of community-dwelling older adults linked to Medicare claims from 2000 to 2012, were used. This dataset was used to create a cohort of hospitalized Medicare beneficiaries and examine the effects of functional impairment on total costs to Medicare of postacute care for up to 365 days after an incident hospitalization. It was hypothesized that functional impairment would be associated with higher costs of care and that severity of impairment would be correlated with higher costs even after adjustments for clinical and demographic features. Greater understanding of functional impairment is crucial to reducing costs of care and increasing attention on unmeasured functional impairment in older, hospitalized adults.
METHODS

Participants
HRS was designed to examine changes in health and wealth as people age. 26 HRS is an ongoing nationally representative, longitudinal study of participants aged 50 and older with follow-up surveys administered to all participants in waves every 2 years; response rates range from 80% to 90%, and more than 85% of participants agree to have their responses linked to their Medicare claims data. The study started in 1992, and new community-dwelling participants are recruited every 6 years to remain representative of the aging U.S. population. 1, 27, 28 A cohort of community-dwelling participants aged 65 and older admitted to a hospital between January 1, 2000, and December 31, 2011, was created to allow for 365 days of follow-up through 2012. To identify hospital admissions, HRS survey data were linked to Medicare claims, and inpatient claims were searched for in Medicare files; 11,793 participants with at least one admission to an eligible hospital (acute care hospitals only; no rehabilitation or Prospective Payment System-exempt cancer hospitals) during the sampling frame were identified. Individuals were excluded for the following reasons: transition to health maintenance organization plan after discharge because complete claims data are not available for managed care admissions (n = 1,924, 16%), death in hospital or within 30 days of discharge (n = 714, 6%), less than 12 months of Medicare claims before admission (required to determine comorbidities from International Classification of Diseases, Ninth Revision (ICD-9 codes)) (n = 249, 2%), no HRS interview within the preceding 2 survey waves (n = 347, 3%).
Because the objective was to characterize total costs of care for a period of 365 days after an index hospitalization, and the study followed participants over 12 years, multiple 365-day observation periods were allowed for individual participants, provided that these periods did not overlap. Thus, if a participant was admitted again after completing a 365-day observation period, this admission could become another index admission, provided the same inclusion and exclusion criteria above were met for that admission. Figure 1 demonstrates how various events might occur within an initial 365-day observation period. The final sample contained 16,673 index admissions from 8,559 participants.
Measures
Primary Predictor: Functional Impairment
A widely used measure of disability in older adults (activities of daily living (ADLs)) obtained from the HRS interview that most closely preceded the index hospital admission was used. ADLs are a series of self-care activities essential to living independently in the community 29, 30 and include bathing, dressing, transferring, toileting, and eating. An ordinal variable for ADLs reflecting the clinical continuum and natural history of impairment 31 was created with four levels: no impairment, difficulty with any ADL, dependency with one ADL, and dependency with two or more ADLs. Difficulty in an ADL indicates that the task is burdensome but can be accomplished without assistance from another person, whereas dependency in an
Index To assess whether this timing was instrumentally important to any association between preadmission functional status and postacute costs of care, a sensitivity analysis restricted to subjects with functional assessments within 6 months preceding admission was performed.
Main Outcome: Postacute Costs of Care to Medicare
To avoid focusing narrowly on costs of care that occur within the transitional period after discharge, an all-inclusive approach was taken, and postacute care costs were defined as any cost of care billed to Medicare within 1 year of discharge from an incident hospital admission. Medicare data were used to calculate total costs that Medicare paid after each index admission for up to 365 days after discharge. A cumulative variable was used in the Medicare claims dataset created by summing all costs paid from the Medicare trust fund for services cov- 
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Other Measurements
Health and demographic factors shown to affect costs of care in prior studies that could introduce confounding into the analyses were considered. Demographic factors included age, sex, race and ethnicity, marital status, education, income, and wealth. Health factors included the Elixhauser Comorbidity Index score, calculated from ICD-9 codes and any hospitalization within 1 year before the index admission. Comorbidities for the Elixhauser Comorbidity Index were determined using Medicare claims data from the 365 days preceding the index admission. The Elixhauser Comorbidity Index consists of 30 individual conditions, has been shown to predict mortality 1 year after hospitalization more accurately than the Charlson Comorbidity Index Score, 33 and is similar to the proprietary Hierarchical Conditions Category (HCC) that Medicare uses to adjust for comorbidity. 34 All other data above were derived from the HRS survey immediately preceding hospitalization.
Statistical Analysis
Given multiple admissions per HRS participant, admissions rather than individual participants were used as the unit of analysis. This analytical decision also reflects the clinical reality that many older adults face multiple admissions over time and mirrors the analytical approach that the Centers for Medicare and Medicaid Services uses for cost reduction initiatives such as the Hospital Readmission Reduction Program. The relationship between functional impairment and postacute costs was examined using unadjusted and adjusted generalized linear models. Specifically, a log link and a gamma family, which is often called a gamma regression model, was used. Gamma models are often preferred over GLM when using cost as an outcome because they accurately reflect the long-tailed distribution of the data and are able to better adjust for participants with zero costs. 35 Gamma regression was used to adjust outcomes for all demographic and health risk factors described above. Robust variance estimation (sandwich estimator) was used to adjust for repeated admission for the same individual, and unadjusted and adjusted costs are reported from the gamma regression models using the recycled predictions method. 36 Goodness of fit analyses were also performed to calculate c-statistics for the models with and without functional impairment included to determine any marginal predictive benefit beyond that provided by comorbidity and other predictors in the models.
Because longer time since functional measurement and index admission might influence results, a sensitivity analysis limited to admissions with functional measurements taken within the preceding 6 months was also performed. To determine what proportion of total costs was attributable to different settings (e.g. inpatient, skilled nursing facility (SNF), outpatient), dates of service for provider claims ("carrier" costs from Medicare Part B claims) were matched to sites of care whenever possible. For example, if physician claim dates that corresponded to a hospital admission were found, the costs of those claims were combined with costs for the hospital stay (Part A claims). The same procedure was followed for provider (Part B) claims with dates that matched claims for SNF, clinic, home health, for example. (In such cases, both claims are found in Part B but are separate costs attributable to the same visit.)
To compare the relative costs of functional impairment with costs attributable to specific comorbidities, the adjusted mean costs were determined for each Elixhauser comorbidity (30 total), for each level of functional impairment. The adjusted cost difference was determined for each comorbidity and impairment level, and these differences were ranked from greatest to least. Given recent studies suggesting that functional status may be more important than comorbidity in predicting outcomes such as readmission, 14,37 the premise for this analysis was to explore functional impairment as if it were a comorbid condition to make more-direct comparisons regarding associated costs. The prevalence-attributable cost for each comorbidity and impairment level was also determined to account for the varying levels of prevalence for each. 38 All computations were performed using Stata version 12 (Stata Corp., College Station, TX).
RESULTS
Complete data were available for 16,673 index admissions from 8,559 participants. Age ranged from 65 to 105 (mean 78.3 AE 7.8), 58% were female, 85% were white, the average number of Elixhauser comorbidities was (Table 1) . Overall, 4,478 subjects (53%) contributed more than one period of observation to the final sample (average observations per subject was 1.95). The mean costs associated with each index admission and corresponding postacute care was f $29,586 AE 30,055. Approximately 20% of this mean cost ($6,003) was spent within the first 30 days of discharge, with the remaining 80% ($23,583) spent in days 31 to 365.
Total Medicare costs of care for 1 year after discharge increased as the severity of impairment increased in a dose-response fashion (P < .001 for trend); 68% had no functional impairment (mean cost $25,931), 17% had one ADL difficulty ($32,501), 7% were dependent in one ADL ($39,928), and 8% were dependent in two or more ADLs ($45,895) ( Table 2 ). The most severely impaired participants cost 77% more than those with no impairment; adjusted analyses showed that functional status remained an important predictor of Medicare costs even after accounting for comorbidity and demographic characteristics. The effect size for adjusted costs was attenuated to the unadjusted costs, but still substantial (33% more, P for trend <.001; Table 2 ). A sensitivity analysis of adjusted costs restricted to admissions with functional assessment within 6 months of hospitalization showed similar results ($26,665 vs 40,636, or 52% more; data not shown). Adjusted total costs attributable to 30 Elixhauser conditions as compared with functional impairment showed that only three Elixhauser conditions were more expensive than severe functional impairment: lymphoma, metastatic cancer, and paralysis (Table 3) . Prevalence-attributable cost for each Elixhauser condition and level of functional impairment were also considered; severe functional impairment alone (8% prevalence) ranked tenth, and any functional impairment (mild, intermediate, and severe combined; 32% prevalence) ranked fifth.
Considering mean total costs according to setting of care (Figure 2) , costs for rehospitalization were higher for participants with severe functional impairment, but proportions were similar (47% and 51%, respectively). Differences in proportional and total costs according to level of functional impairment were more pronounced for SNF and home health care. Costs of SNF care were nearly three times as high for participants with severe impairment ($9,266) as for those with no impairment ($3,334). Home healthcare costs for participants with severe impairment ($5,678) were also approximately triple costs for those with no impairment ($1,902). Overall, 3,338 (39%) participants had home health costs, 2140 (25%) had SNF costs, and 599 (7%) had hospice costs; 4,365 (51%) had at least one of the three.
Analysis of variance using functional impairment as the primary predictor did not show significant improvement in c-statistic for the model over using Elixhauser comorbities as primary predictor. The c-statistic for participants in highest 20th percentile of overall costs was 0.71 with function in the model and 0.70 without. Similarly, the coefficient of determination for a linear model of logtransformed costs did not indicate significant differences with functional impairment included (0.21) or excluded (0.20) from the models.
DISCUSSION
In this 12-year longitudinal, nationally representative study of cost of postacute care for Medicare beneficiaries, approximately one-third had some level of functional impairment, which was associated with higher overall costs to Medicare. These costs increased in a dose-response fashion as the degree of impairment increased, the most functionally impaired participants had costs nearly 80% higher than those with no impairments ($46,000 vs $26,000). These unadjusted associations demonstrate the value of functional status as a single and simple predictor of the most-resource-intensive episodes of postacute care. The persistence of this association after adjustment for clinical and demographic characteristics highlights functional impairment as an independent predictor of costs that is currently unmeasured in routine hospital care and unreported in Medicare claims data.
Severe functional impairment is very expensive; only individuals with lymphoma, metastatic cancer, and paralysis had higher adjusted costs. Recent interest in identifying frail, vulnerable, or otherwise at-risk older adults in the hospital has drawn attention to the specific role of functional impairment in this population, but very few studies, with small sample sizes, have explored associations Moreover, it is not clear to what extent functional impairments that are part of frailty or vulnerability scales drive such associations. The current study findings build on this small but important body of literature and suggest that functional impairment, in addition to comorbidity, is an important but overlooked marker of cost of care in this population. Current efforts to reduce cost target common diagnoses (e.g. heart failure, hip fractures), but most older adults have multiple comorbidities, and functional status is the result of these disease processes, which cuts across diagnoses. Interventions targeted at Medicare beneficiaries according to level of function may be a more-effective way of targeting high costs because functional status is an indicator of the effect of disease on older adults, especially after an episode of acute care. In addition to the high cost of functional impairment to Medicare for medical care, there are considerable out-of-pocket costs to beneficiaries and their caregivers not captured in the current analysis. 41, 42 Given the high medical usage rates of individuals with functional impairment, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] it may be that certain events such as readmission are related to unmet needs or "missing pieces" of the postacute plan for recovery. 43 Disability has been broadly defined as "any gap between personal capability and situational demand" 44 and unrecognized functional impairment that has created or worsened such a gap to an extent that prompts return to the hospital to meet these needs may be driving many so-called "social admissions." Older adults are particularly at risk of poor outcomes due to such gaps in the postacute period, 45 and each successive hospital admission increases the risk of accelerated functional decline and permanent disability. 46 Moreover, at least half of permanent disability in older adults begins with functional decline during hospitalization. 47 This vicious cycle of worsening functional impairment and increased use underscores the urgent need to incorporate functional assessments into routine hospital care. Medicare and other payers do not require acute care hospitals to collect and report any measures of functional status in hospitalized older adults or provide incentives for them to do so. In contrast, postacute care settings such as SNFs, inpatient rehabilitation facilities, and home health care providers are required to report functional status. Functional status should be assessed during acute care as well-ideally on admission and discharge at minimum. This study has several limitations. First, given the prospective nature of the HRS, the time from measurements of functional impairment and hospitalization were not uniform (interquartile range 202-614 days, average 423 days). Although a subanalysis of admissions with functional assessments within 6 months preceding admission was not significantly different from the main results, the analysis may have underestimated the effects of functional impairments at the time of hospital admission because functional status typically declines in the setting of acute illness. 8 Second, the correlations found between functional impairment and cost do not demonstrate causation; further research is needed to understand the mechanisms that result in higher costs for these individuals. Third, the analysis adjusts for comorbidity (presence or absence of various conditions) but does not account for multimorbidity (interactions between multiple morbidities); it is possible that adjustment for these interactions could mute the effect of functional impairment found. Fourth, although it was not found that functional status explained significantly more variance in costs than predicted from the Elixhauser index alone, clinicians can assess the former much more easily than the latter at the bedside and apply it to the individual and family in front of them when thinking about costs of postacute care. Finally, perhaps the most important limitation is that only costs to Medicare could be analyzed; functional impairment imposes tremendous out-of-pockets costs on individuals and caregivers, so it is likely that the findings were a gross underestimate of total costs. Future studies should attempt to combine these individual and caregiver costs with billing data to attain a more-accurate understanding of the aggregate costs of functional impairment on society.
In conclusion, functional impairment is associated with higher Medicare postacute care costs in older adults, with disproportionate spending for SNF and home health, than in those with no impairment. These findings suggest the need for Medicare policy to expand beyond the traditional focus on chronic disease management and explore initiatives to manage advanced functional impairment to reduce overall costs of postacute care for community-dwelling older adults. Functional impairment at admission may be an overlooked but highly suitable target for interventions to reduce the cost of postacute care in Medicare beneficiaries. SRG had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
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